{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:09:59Z","timestamp":1777504199262,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Scientific Research and Innovation Fund of the First affiliated Hospital of Harbin Medical University","award":["2020B15"],"award-info":[{"award-number":["2020B15"]}]},{"name":"Foundation for the Dean of Southern University of Science and Technology Hospital in 2020","award":["2020-A3"],"award-info":[{"award-number":["2020-A3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10637-021-01079-5","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T08:15:19Z","timestamp":1612944919000},"page":"961-970","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Histone deacetylase inhibitor chidamide regulates the Wnt\/\u03b2-catenin pathway by MYCN\/DKK3 in B-ALL"],"prefix":"10.1007","volume":"39","author":[{"given":"Linlin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengfang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhibo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sicheng","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desheng","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leilei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"1079_CR1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00018-017-2620-z","volume":"75","author":"C Malouf","year":"2017","unstructured":"Malouf C, Ottersbach K (2017) Molecular processes involved in B cell acute lymphoblastic leukaemia. Cell Mol Life Sci 75:417\u2013446. https:\/\/doi.org\/10.1007\/s00018-017-2620-z","journal-title":"Cell Mol Life Sci"},{"key":"1079_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fimmu.2018.00239","volume":"9","author":"T Ciprian","year":"2018","unstructured":"Ciprian T, Shigeo F, Cristian B, Onaciu A, Chira S, Petrushev B, Micu WT, Moisoiu V, Osan C, Constantinescu C, Pasca S, Jurj A, Pop L, Berindan-Neagoe I, Dima D, Kitano S (2018) Chimeric antigen receptor T-cells for the treatment of B-cell acute lymphoblastic leukemia. Front Immunol 9:239\u2013251. https:\/\/doi.org\/10.3389\/fimmu.2018.00239","journal-title":"Front Immunol"},{"key":"1079_CR3","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.mayocp.2016.09.010","volume":"91","author":"S Paul","year":"2016","unstructured":"Paul S, Kantarjian H, Jabbour EJ (2016) Adult acute lymphoblastic leukemia. Mayo Clin Proc 91:1645\u20131666. https:\/\/doi.org\/10.1016\/j.mayocp.2016.09.010","journal-title":"Mayo Clin Proc"},{"key":"1079_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.critrevonc.2015.12.007","volume":"99","author":"OA Ustwani","year":"2015","unstructured":"Ustwani OA, Gupta N, Bakhribah H, Griffiths EA, Wang ES, Wetzler M (2015) Clinical updates in adult acute lymphoblastic leukemia. Crit Rev Oncol Hematol 99:189\u2013199. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.12.007","journal-title":"Crit Rev Oncol Hematol"},{"key":"1079_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1182\/blood-2014-09-551937","volume":"126","author":"NV Frey","year":"2015","unstructured":"Frey NV, Luger SM (2015) How I treat adults with relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia. Blood 126:589\u2013596. https:\/\/doi.org\/10.1182\/blood-2014-09-551937","journal-title":"Blood"},{"key":"1079_CR6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1365-2141.2007.06667.x","volume":"138","author":"NI Khan","year":"2007","unstructured":"Khan NI, Bradstock KF, Bendall LJ (2007) Activation of Wnt\/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. Br J Haematol 138:338\u2013348. https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06667.x","journal-title":"Br J Haematol"},{"key":"1079_CR7","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.1182\/blood-2011-04-350850","volume":"118","author":"A Kuhnl","year":"2011","unstructured":"Kuhnl A, Gokbuget N, Kaiser M, Schlee C, Stroux A, Burmeister T, Mochmann LH, Hoelzer D, Hofmann WK, Thiel E, Baldus CD (2011) Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia. Blood 118:6362\u20136367. https:\/\/doi.org\/10.1182\/blood-2011-04-350850","journal-title":"Blood"},{"key":"1079_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ijc.23913","volume":"124","author":"EJ Lee","year":"2010","unstructured":"Lee EJ, Jo M, Rho SB, Park K, Yoo YN, Park J, Chae M, Zhang W, Lee JH (2010) Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin. Int J Cancer 124:287\u2013297. https:\/\/doi.org\/10.1002\/ijc.23913","journal-title":"Int J Cancer"},{"key":"1079_CR9","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/onc.2009.512","volume":"29","author":"WC Gustafson","year":"2010","unstructured":"Gustafson WC, Weiss WA (2010) Myc proteins as therapeutic targets. Oncogene 29:1249\u20131259. https:\/\/doi.org\/10.1038\/onc.2009.512","journal-title":"Oncogene"},{"key":"1079_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.canlet.2015.03.044","volume":"363","author":"L Evans","year":"2015","unstructured":"Evans L, Chen L, Milazzo G, Gherardi S, Perini G, Willmore E, Newell DR, Tweddle DA (2015) SKP2 is a direct transcriptional target of MYCN and a potential therapeutic target in neuroblastoma. Cancer Lett 363:37\u201345. https:\/\/doi.org\/10.1016\/j.canlet.2015.03.044","journal-title":"Cancer Lett"},{"key":"1079_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/mc.21994","volume":"53","author":"J Charlet","year":"2014","unstructured":"Charlet J, Szemes M, Malik KT, Brown KW (2014) MYCN is recruited to the RASSF1A promoter but is not critical for DNA hypermethylation in neuroblastoma. Mol Carcinog 53:413\u2013420. https:\/\/doi.org\/10.1002\/mc.21994","journal-title":"Mol Carcinog"},{"key":"1079_CR12","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1111\/jcmm.13644","volume":"22","author":"D Kong","year":"2018","unstructured":"Kong D, Zhao L, Sun L, Fan S, Li H, Zhao Y, Guo Z, Lin L, Cui L, Wang K, Chen W, Zhang Y, Zhou J, Li Y (2018) MYCN is a novel oncogenic target in adult B-ALL that activates the Wnt\/\u03b2-catenin pathway by suppressing DKK3. J Cell Mol Med 22:3627\u20133637. https:\/\/doi.org\/10.1111\/jcmm.13644","journal-title":"J Cell Mol Med"},{"key":"1079_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s13402-015-0233-9","volume":"38","author":"C Cort\u00e9s","year":"2015","unstructured":"Cort\u00e9s C, Kozma SC, Tauler A, Ambrosio S (2015) MYCN concurrence with SAHA-induced cell death in human neuroblastoma cells. Cell Oncol 38:341\u2013352. https:\/\/doi.org\/10.1007\/s13402-015-0233-9","journal-title":"Cell Oncol"},{"key":"1079_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.5582\/irdr.2016.01024","volume":"5","author":"X Lu","year":"2016","unstructured":"Lu X, Ning Z, Li Z, Cao H, Wang X (2016) Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China. Intractable Rare Dis Res 5:185\u2013191. https:\/\/doi.org\/10.5582\/irdr.2016.01024","journal-title":"Intractable Rare Dis Res"},{"key":"1079_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1042\/BJ20111685","volume":"443","author":"K Gong","year":"2012","unstructured":"Gong K, Xie J, Yi H, Li WH (2012) CS055 (Chidamide\/HBI-8000), a novel histone deacetylase inhibitor, induces G1 arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells. Biochem J 443:735\u2013746. https:\/\/doi.org\/10.1042\/BJ20111685","journal-title":"Biochem J"},{"key":"1079_CR16","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJMra1400972","volume":"373","author":"SP Hunger","year":"2015","unstructured":"Hunger SP, Mullighan CG (2015) Acute lymphoblastic leukemia in children. N Engl J Med 373:1541\u20131552. https:\/\/doi.org\/10.1056\/NEJMra1400972","journal-title":"N Engl J Med"},{"key":"1079_CR17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1080\/10428194.2017.1335397","volume":"59","author":"A Kansagra","year":"2018","unstructured":"Kansagra A, Dahiya S, Litzow M (2018) Continuing challenges and current issues in acute lymphoblastic leukemia. Leuk Lymphoma 59:526\u2013541. https:\/\/doi.org\/10.1080\/10428194.2017.1335397","journal-title":"Leuk Lymphoma"},{"key":"1079_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrc2765","volume":"10","author":"J Chen","year":"2010","unstructured":"Chen J, Odenike O, Rowley JD (2010) Leukaemogenesis: more than mutant genes. Nat Rev Cancer 10:23\u201336. https:\/\/doi.org\/10.1038\/nrc2765","journal-title":"Nat Rev Cancer"},{"key":"1079_CR19","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s00018-010-0624-z","volume":"68","author":"M Hatziapostolou","year":"2011","unstructured":"Hatziapostolou M, Iliopoulos D (2011) Epigenetic aberrations during oncogenesis. Cell Mol Life Sci 68:1681\u20131702. https:\/\/doi.org\/10.1007\/s00018-010-0624-z","journal-title":"Cell Mol Life Sci"},{"key":"1079_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.blre.2005.01.006","volume":"20","author":"O Galm","year":"2006","unstructured":"Galm O, Herman JG, Baylin SB (2006) The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev 20:1\u201313. https:\/\/doi.org\/10.1016\/j.blre.2005.01.006","journal-title":"Blood Rev"},{"key":"1079_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.bmhimx.2017.02.005","volume":"74","author":"MDP Navarrete-Meneses","year":"2017","unstructured":"Navarrete-Meneses MDP, P\u00e9rez-Vera P (2017) Epigenetic alterations in acute lymphoblastic leukemia. Bol Med Hosp Infant Mex 74:243\u2013264. https:\/\/doi.org\/10.1016\/j.bmhimx.2017.02.005","journal-title":"Bol Med Hosp Infant Mex"},{"key":"1079_CR22","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nrc3130","volume":"11","author":"SB Baylin","year":"2011","unstructured":"Baylin SB, Jones PA (2011) A decade of exploring the cancer epigenome-biological and translational implications. Nat Rev Cancer 11:726\u2013734. https:\/\/doi.org\/10.1038\/nrc3130","journal-title":"Nat Rev Cancer"},{"key":"1079_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13148-015-0151-8","volume":"7","author":"C Zhang","year":"2015","unstructured":"Zhang C, Zhong JF, Stucky A, Chen XL, Press MF, Zhang X (2015) Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia. Clin Epigenetics 7:117\u2013131. https:\/\/doi.org\/10.1186\/s13148-015-0151-8","journal-title":"Clin Epigenetics"},{"key":"1079_CR24","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1158\/1078-0432.CCR-14-1290","volume":"21","author":"MC Stubbs","year":"2015","unstructured":"Stubbs MC, Kim W, Bariteau M, Davis T, Vempati S, Minehart J, Witkin M, Qi J, Krivtsov AV, Bradner JE, Kung AL, Armstrong SA (2015) Selective inhibition of HDAC1 and HDAC2 as a potential therapeutic option for B-ALL. Clin Cancer Res 21:2348\u20132358. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-1290","journal-title":"Clin Cancer Res"},{"key":"1079_CR25","first-page":"2567","volume":"10","author":"J Mao","year":"2018","unstructured":"Mao J, Li S, Zhao H, Zhu Y, Hong M, Zhu H, Qian S, Li J (2018) Effects of chidamide and its combination with decitabine on proliferation and apoptosis of leukemia cell lines. Am J Transl Res 10:2567\u20132578","journal-title":"Am J Transl Res"},{"key":"1079_CR26","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.3389\/fonc.2019.01276","volume":"9","author":"H Huang","year":"2019","unstructured":"Huang H, Wenbing Y, Dong A, He Z, Yao R, Guo W (2019) Chidamide enhances the cytotoxicity of cytarabine and sorafenib in acute myeloid leukemia cells by modulating H3K9me3 and autophagy levels. Front Oncol 9:1276. https:\/\/doi.org\/10.3389\/fonc.2019.01276","journal-title":"Front Oncol"},{"key":"1079_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13148-019-0723-0","volume":"11","author":"J Ye","year":"2019","unstructured":"Ye J, Zha J, Shi Y, Li Y, Yuan D, Chen Q, Lin F, Fang Z, Yu Y, Dai Y, Xu B (2019) Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair. Clin Epigenetics 11:137. https:\/\/doi.org\/10.1186\/s13148-019-0723-0","journal-title":"Clin Epigenetics"},{"key":"1079_CR28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.biopha.2017.04.037","volume":"90","author":"X Li","year":"2017","unstructured":"Li X, Yan X, Guo W, Huang X, Huang J, Yu M, Ma Z, Xu Y, Huang S, Li C, Zhou Y, Jin J (2017) Chidamide in FLT3-ITD positive acute myeloid leukemia and the synergistic effect in combination with cytarabine. Biomed Pharmacother 90:699\u2013704. https:\/\/doi.org\/10.1016\/j.biopha.2017.04.037","journal-title":"Biomed Pharmacother"},{"key":"1079_CR29","first-page":"3169","volume":"8","author":"S Zhao","year":"2016","unstructured":"Zhao S, Guo J, Zhao Y, Fei C, Zheng Q, Li X, Chang C (2016) Chidamide, a novel histone deacetylase inhibitor, inhibits the viability of MDS and AML cells by suppressing JAK2\/STAT3 signaling. Am J Transl Res 8:3169\u20133178","journal-title":"Am J Transl Res"},{"key":"1079_CR30","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1080\/10428194.2019.1691195","volume":"61","author":"W Guan","year":"2020","unstructured":"Guan W, Jing Y, Dou L, Wang M, Xiao Y, Yu L (2020) Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma\/leukemia. Leuk Lymphoma 61:855\u2013861. https:\/\/doi.org\/10.1080\/10428194.2019.1691195","journal-title":"Leuk Lymphoma"},{"key":"1079_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41419-019-2210-0","volume":"11","author":"XW Guan","year":"2020","unstructured":"Guan XW, Wang HQ, Ban WW, Chang Z, Chen H, Jia L, Liu F (2020) Novel HDAC inhibitor Chidamide synergizes with rituximab to inhibit diffuse large B-cell lymphoma tumour growth by upregulating CD20. Cell Death Dis 11:20. https:\/\/doi.org\/10.1038\/s41419-019-2210-0","journal-title":"Cell Death Dis"},{"key":"1079_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.leukres.2017.01.025","volume":"56","author":"H Zhang","year":"2017","unstructured":"Zhang H, Dong L, Chen Q, Kong L, Meng B, Wang H, Fu K, Wang X, Panhammarstrom Q, Wang P, Wang X (2017) Synergistic antitumor effect of histone deacetylase inhibitor and doxorubicin in peripheral T-cell lymphoma. Leuk Res 56:29\u201335. https:\/\/doi.org\/10.1016\/j.leukres.2017.01.025","journal-title":"Leuk Res"},{"key":"1079_CR33","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3892\/mmr.2019.10873","volume":"21","author":"Z Chi","year":"2020","unstructured":"Chi Z, Gao H, Liu H, Wu B, Zhang B, Gu M, Yang W (2020) Chidamide induces necroptosis via regulation of c FLIPL expression in Jurkat and HUT 78 cells. Mol Med Rep 21:936\u2013944. https:\/\/doi.org\/10.3892\/mmr.2019.10873","journal-title":"Mol Med Rep"},{"key":"1079_CR34","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/sj.embor.embor861","volume":"4","author":"SR Frank","year":"2003","unstructured":"Frank SR, Parisi T, Taubert S, Fernandez P, Fuchs M, Chan HM, Livingston DM, Amati B (2003) MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep 4:575\u2013580. https:\/\/doi.org\/10.1038\/sj.embor.embor861","journal-title":"EMBO Rep"},{"key":"1079_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.canlet.2011.11.036","volume":"318","author":"R Francisco","year":"2012","unstructured":"Francisco R, P\u00e9rez-Perarnau A, Cort\u00e9s C, Gil J, Tauler A, Ambrosio S (2012) Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells. Cancer Lett 318:42\u201352. https:\/\/doi.org\/10.1016\/j.canlet.2011.11.036","journal-title":"Cancer Lett"},{"key":"1079_CR36","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1182\/blood-2006-09-047043","volume":"109","author":"J Rom\u00e1n-G\u00f3mez","year":"2007","unstructured":"Rom\u00e1n-G\u00f3mez J, Cordeu L, Agirre X, Jim\u00e9nez-Velasco A, San Jos\u00e9-Eneriz E, Garate L, Calasanz MJ, Heiniger A, Torres A, Prosper F (2007) Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. Blood 109:3462\u20133469. https:\/\/doi.org\/10.1182\/blood-2006-09-047043","journal-title":"Blood"},{"key":"1079_CR37","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1101\/gad.1295405","volume":"19","author":"A Gregorieff","year":"2005","unstructured":"Gregorieff A, Clevers H (2005) Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev 19:877\u2013890. https:\/\/doi.org\/10.1101\/gad.1295405","journal-title":"Genes Dev"},{"key":"1079_CR38","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.2741\/1933","volume":"11","author":"HC Lee","year":"2006","unstructured":"Lee HC, Kim M, Wands JR (2006) Wnt\/frizzled signaling in hepatocellular carcinoma. Front Biosci 11:1901\u20131915. https:\/\/doi.org\/10.2741\/1933","journal-title":"Front Biosci"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-021-01079-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-021-01079-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-021-01079-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T05:06:25Z","timestamp":1678511185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-021-01079-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1079"],"URL":"https:\/\/doi.org\/10.1007\/s10637-021-01079-5","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"assertion":[{"value":"27 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocols used for animal studies were approved by the Laboratory Animal Ethics Committee of Southern University of Science and Technology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The protocols used for animal studies were approved by the Laboratory Animal Ethics Committee of Southern University of Science and Technology, and all procedures followed internationally accepted principles and the Guidelines of the Animal Care and Use.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"The authors declare no conflicts of interest.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}